Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Micrologix receives broad patent coverage for peptide antibiotic production method

Jan. 31, 1997

Novel antiinfective agents from Tanabe

Jan. 31, 1997

Bayer to market Amphotec in Canada

Jan. 30, 1997

Nobel Laureate to study bacterial resistance to nisin

Jan. 30, 1997

Famvir safe and effective in HIV-infected patients with shingles

Jan. 30, 1997

Microcide reports new cephalosporin antibiotics

Jan. 30, 1997

Synthelabo investigates oxazolidinones

Jan. 30, 1997

N-oxide antibacterial compounds from Bayer

Jan. 30, 1997

New cephem antibacterial agents from Takeda

Jan. 30, 1997

Schering-Plough claims tetrahydrofuran antifungal agents

Jan. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...